Loading...
MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks
Glioblastoma Multiforme (GBM), a malignant brain tumor, is among the most lethal of all cancers. Temozolomide is the primary chemotherapy treatment for patients diagnosed with GBM. The methylation status of the promoter or the enhancer regions of the O(6−) methylguanine methyltransferase (MGMT) gene...
Na minha lista:
| Udgivet i: | Pac Symp Biocomput |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5728677/ https://ncbi.nlm.nih.gov/pubmed/29218894 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|